Lamictal (Lamotrigine)

Lamotrigine works by inhibiting voltage‑gated sodium channels on neuronal membranes, which stabilises the membrane and limits the release of excitatory neurotransmitters such as glutamate. This reduction in neuronal hyper‑excitability underlies its effectiveness in controlling seizures and in moderating mood swings associated with bipolar disorder.

The exact dose of Lamictal is determined by the prescribing clinician based on the patient’s age, weight, renal and hepatic function, and the specific condition being treated. Dosage is typically started low and increased gradually to minimise the risk of skin reactions, with adjustments made for interacting medications.

Safety data for lamotrigine in pregnancy are limited, and the drug is classified as having an unknown pregnancy risk. It should only be used when the potential benefit justifies any potential risk to the fetus. Limited information suggests that lamotrigine does pass into breast milk, so a risk‑benefit assessment is required before breastfeeding.

To order Lamictal, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After the request, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements) and assist with import documentation.

Lamictal differs from carbamazepine in its mechanism and side‑effect profile. While both reduce seizure activity, lamotrigine has a lower risk of inducing hyponatremia and fewer drug‑induced liver enzyme elevations. However, lamotrigine carries a higher risk of severe skin reactions, especially when combined with valproic acid, and requires slower titration compared with carbamazepine.

Lamictal tablets should be stored at ambient temperature, preferably below 25 °C. Keep the medication in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability throughout its shelf life.

Lamictal is administered orally, usually as a tablet taken with or without food. The prescribing physician will set the dosing schedule, which often starts with a low dose and is increased gradually. Patients should follow the exact timing and dosage instructions provided by their healthcare professional.

The most serious risks of Lamictal include severe skin reactions such as Stevens‑Johnson syndrome and toxic epidermal necrolysis, which can be life‑threatening. Hematologic abnormalities like agranulocytosis, hepatic failure, and the emergence of suicidal thoughts or depressive symptoms are also rare but critical concerns that require immediate medical attention.

Lamictal should be avoided in individuals with a known hypersensitivity to lamotrigine or any of its excipients. Patients with a history of severe cutaneous adverse reactions to other medications, or those taking contraindicated enzyme‑inducing antiepileptics without proper dose adjustment, should not initiate therapy without specialist guidance.